You are here: Home :: Area NEM :: Medical science :: Human medicine

Martin den Heijer

Hyperhomocysteinaemia as a Risk Factor for Venous Thrombosis: An Update of the Current Evidence

Classical homocystinuria is associated with arterial vascular diseases and venous thrombosis. In the last decade, many studies, including some prospective studies, have been published indicating that moderate hyperhomocysteinaemia is also a risk factor for venous thrombosis. The 677C>T mutation in the methylenetetrahydrofolate reductase (MTHFR) gene is an important cause of mild hyperhomocysteinaemia. Recent meta-analyses show an elevated risk of venous thrombosis for subjects with the TT-genotype. Based on the concept of ‘Mendelian randomisation’, this observation supports the hypothesis that hyperhomocysteinaemia is a causal risk factor for venous thrombosis. The results of one homocysteine-lowering trial regarding venous thrombosis are awaited at the end of 2003. In this paper the current evidence for hyperhomocysteinaemia as a risk factor for venous thrombosis is being discussed.

Clinical Chemical Laboratory Medicine, Walter de Gruyter

Print ISSN: 1434-6621
Volume: 41, 11/2003
Pages: 1404 - 1407

Show full article (external site)

Show all available items of this journal

 

Area NEM